CVAT
Cavitation Technologies, Inc.0.0500
-0.0100-16.7%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
14.46MP/E (TTM)
-Basic EPS (TTM)
0.00Dividend Yield
0%Recent Filings
10-Q
Q2 FY2026 results
Cavitation Technologies posted zero revenue in Q2 FY2026 ended December 31, 2025, down 100% y/y from $76,000, with $3,000 YTD versus $76,000 prior year; operating loss widened to $474,000 from $299,000 y/y on higher G&A from $244,000 stock compensation for services, while R&D dropped 75%. Net loss hit $476,000, matching operating loss but differing from YTD $734,000 net loss due to $11,000 interest. Cash dwindled to $31,000 from $249,000 at June 30 amid $401,000 operating burn; $150,000 EIDL debt at 3.75% and $3,000 net convertible note persist, offset by $173,000 equity raise. Issued shares via cashless warrants. Xyra pushes crypto cooling. Going concern wobbles.
10-Q
Q1 FY2026 results
Cavitation Technologies posted Q1 FY2026 revenue of $3,000 from equipment rental, up from zero a year ago, yet operating loss widened to $249,000 (up 10.2% y/y) on higher G&A expenses while R&D dipped. Net loss hit $258,000, mainly from $9,000 interest on the $150,000 EIDL note (3.75%, due 2050). Cash drained to $30,000 after $219,000 operating outflow; stockholders' deficit turned negative at $189,000. Cash lasts through December 2025. EPS reconciles at $(0.00) across 289M shares. Licensing shift to water and beverages eyes growth. Going concern hangs by a thread.
10-K
FY2025 results
Cavitation Technologies posted FY2025 revenue of $203,000, down 85% year-over-year from $1.36 million, driven by sharply reduced Nano Reactor sales to Desmet before the October 2024 patent assignment that fetched an $880,000 gain. This one-time boost turned an operating loss of $987,000 into a slim net loss of $113,000, while cash climbed to $249,000 amid $806,000 in operating outflows. No quarterly breakdowns emerged, but trials in Permian Basin water remediation and Canadian agriculture hint at Q1 FY2026 momentum, with Hydro-Plasma tech testing underway. The firm settled related-party debts via stock and warrants, preserving liquidity without dividends or buybacks. No annual guidance surfaced, yet revenue from new ventures could accelerate. Cybersecurity threats loom, risking IP and operations.
10-Q
Q3 FY2025 results
Cavitation Technologies posted Q3 FY2025 revenue of $122,000, down 76.5% y/y from $519,000, reflecting the October 2024 patent assignment to Desmet that curbed Nano Reactor sales; nine-month revenue fell 72.2% y/y to $198,000, yet a $880,000 gain on the assignment flipped operations loss of $753,000 into net income of $122,000, up 90.6% y/y. Gross margin held at 79.5% for the quarter, while operating expenses climbed 81.6% y/y to $325,000, driven by $90,000 in stock-based compensation and higher R&D. Cash swelled to $432,000 on the deal's proceeds, with $624,000 used in operations; total debt stands at $136,000 under the EIDL note at 3.75%. The patent deal secured a royalty-free license for water treatment and beverage applications, fueling pilots in the Permian Basin and agriculture. Patent sales to Desmet unlocked fresh paths.
10-Q
Q2 FY2025 results
Cavitation Technologies swung to a net income of $579,000 for Q2 FY2025 ended December 31, 2024, from a $16,000 loss a year earlier, driven by an $880,000 gain on patent assignment to Desmet that offset a 60.4% y/y revenue drop to $76,000 from Nano Reactor sales. Gross margin held steady at 82.9%, yet operating loss widened to $299,000 from $14,000 due to higher G&A expenses, including $105,000 in warrant compensation. The patent deal, closed October 9, 2024, for $880,000 cash, assigned vegetable oil patents while reserving exclusive rights for water/wastewater and alcoholic beverage applications. Cash climbed to $681,000, with $128,000 long-term EIDL debt at 3.75%; free cash flow not disclosed in the 10-Q. EPS reconciles at $0.00 with 284.3 million diluted shares. Patent assignment unlocked fresh paths. Regulatory hurdles in water treatment markets loom large.
IPO
Website
Employees
Sector
Industry
CETY
Clean Energy Technologies, Inc.
0.98+0.03
CGEH
Capstone Green Energy Holdings
5.00-0.75
CHMX
Next-ChemX Corporation
0.01+0.00
CLEV
Concrete Leveling Systems Inc.
0.39+0.00
CVV
CVD Equipment Corporation
3.07-0.07
ITT
ITT Inc.
175.05+1.00
NDSN
Nordson Corporation
236.37-1.42
NEWH
NewHydrogen Inc.
0.02+0.00
NNE
Nano Nuclear Energy Inc.
32.31+0.96
WTS
Watts Water Technologies, Inc.
279.25-2.01